Anemia Management in the Cancer Patient With CKD and End-Stage Kidney Disease

Arash Rashidi; Pranav S. Garimella; Abdullah Al-Asaad; Talar Kharadjian; Mariela Navarro Torres; Jyotsana Thakkar

doi:10.1053/j.ackd.2022.03.005

Anemia Management in the Cancer Patient With CKD and End-Stage Kidney Disease

Arash Rashidi, Pranav S. Garimella, Abdullah Al-Asaad, Talar Kharadjian, Mariela Navarro Torres, Jyotsana Thakkar

Medicine

Research output: Contribution to journal › Review article › peer-review

2 Scopus citations

Abstract

Anemia is a common medical problem among patients with cancer and chronic kidney disease (CKD). Although anemia in patients with CKD is often treated with iron and erythropoietin-stimulating agents, there are controversies with regard to the use of erythropoietin-stimulating agents in cancer patients. In this article, we review the treatment of anemia in patients with cancer and CKD, in addition to summarizing the current guidelines in treatment of anemia in these patients.

Original language	English (US)
Pages (from-to)	180-187.e1
Journal	Advances in Chronic Kidney Disease
Volume	29
Issue number	2
DOIs	https://doi.org/10.1053/j.ackd.2022.03.005
State	Published - Mar 2022

Keywords

Anemia
CKD
Cancer
Dialysis
ESA
Iron

ASJC Scopus subject areas

Nephrology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1053/j.ackd.2022.03.005

Cite this

@article{9b4b1a6335064001afd6329639a78b04,

title = "Anemia Management in the Cancer Patient With CKD and End-Stage Kidney Disease",

abstract = "Anemia is a common medical problem among patients with cancer and chronic kidney disease (CKD). Although anemia in patients with CKD is often treated with iron and erythropoietin-stimulating agents, there are controversies with regard to the use of erythropoietin-stimulating agents in cancer patients. In this article, we review the treatment of anemia in patients with cancer and CKD, in addition to summarizing the current guidelines in treatment of anemia in these patients.",

keywords = "Anemia, CKD, Cancer, Dialysis, ESA, Iron",

author = "Arash Rashidi and Garimella, {Pranav S.} and Abdullah Al-Asaad and Talar Kharadjian and Torres, {Mariela Navarro} and Jyotsana Thakkar",

note = "Publisher Copyright: {\textcopyright} 2022 National Kidney Foundation, Inc.",

year = "2022",

month = mar,

doi = "10.1053/j.ackd.2022.03.005",

language = "English (US)",

volume = "29",

pages = "180--187.e1",

journal = "Advances in Chronic Kidney Disease",

issn = "1548-5595",

publisher = "W.B. Saunders Ltd",

number = "2",

}

TY - JOUR

T1 - Anemia Management in the Cancer Patient With CKD and End-Stage Kidney Disease

AU - Rashidi, Arash

AU - Garimella, Pranav S.

AU - Al-Asaad, Abdullah

AU - Kharadjian, Talar

AU - Torres, Mariela Navarro

AU - Thakkar, Jyotsana

PY - 2022/3

Y1 - 2022/3

N2 - Anemia is a common medical problem among patients with cancer and chronic kidney disease (CKD). Although anemia in patients with CKD is often treated with iron and erythropoietin-stimulating agents, there are controversies with regard to the use of erythropoietin-stimulating agents in cancer patients. In this article, we review the treatment of anemia in patients with cancer and CKD, in addition to summarizing the current guidelines in treatment of anemia in these patients.

AB - Anemia is a common medical problem among patients with cancer and chronic kidney disease (CKD). Although anemia in patients with CKD is often treated with iron and erythropoietin-stimulating agents, there are controversies with regard to the use of erythropoietin-stimulating agents in cancer patients. In this article, we review the treatment of anemia in patients with cancer and CKD, in addition to summarizing the current guidelines in treatment of anemia in these patients.

KW - Anemia

KW - CKD

KW - Cancer

KW - Dialysis

KW - ESA

KW - Iron

UR - http://www.scopus.com/inward/record.url?scp=85133781678&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85133781678&partnerID=8YFLogxK

U2 - 10.1053/j.ackd.2022.03.005

DO - 10.1053/j.ackd.2022.03.005

M3 - Review article

C2 - 35817525

AN - SCOPUS:85133781678

SN - 1548-5595

VL - 29

SP - 180-187.e1

JO - Advances in Chronic Kidney Disease

JF - Advances in Chronic Kidney Disease

IS - 2

ER -

Anemia Management in the Cancer Patient With CKD and End-Stage Kidney Disease

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this